Principal Financial Group
THRX

Principal Financial Group’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Principal Financial Group’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,216
Closed -$41.4K – 2528
2023
Q4 		$41.4K Sell
10,216
-463
-4% -$1.41K ﹤0.01% 2344
2023
Q3 		$28.7K Hold
10,679
– – ﹤0.01% 2385
2023
Q2 		$99.6K Buy
+10,679
New +$105K ﹤0.01% 2290

Principal Financial Group's THRX Position: Q1 2024 in Review

Principal Financial Group sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 10,216 shares — an estimated $41.4K sold.

Principal Financial Group first reported a position in THRX in Q2 2023 and held it in 3 quarters. The position peaked at $99.6K in Q2 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

  • Principal Financial Group reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Principal Financial Group sold 10,216 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $41.4K.
  • Principal Financial Group first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Principal Financial Group's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $99.6K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Principal Financial Group's 13F filing for Q1 2024, filed 29 Apr 2024.